Comparative study for brain delivery of tacrine using polysorbate 80 - Coated poly(butylcyanoacrylate) and pegylated-poly(butylcyanoacrylate) nanoparticles

International Journal of Nano and Biomaterials

Volumn 2, Issue 1-5, 2009, Pages 360-374

  Abdel Wahab, Basel A ^a   Abdel Latif, Mohamed M ^b   Abdel Hafez, Atef A ^c  

^a NAJRAN UNIVERSITY   (Saudi Arabia)

^b Assiut University   (Egypt)

^c TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

BBB; Blood brain barrier; Brain targeting; Nanoparticles; PBCA; Pegylted PBCA nanoparticles; Poly(butylcyanoacrylate); Tacrine

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; NANOPARTICLES; RATS;

BLOOD-BRAIN BARRIER; BRAIN TARGETING; PBCA; POLY(BUTYLCYANOACRYLATE); TACRINE;

TARGETED DRUG DELIVERY;

NANOPARTICLE; POLYETHYLENE GLYCOL POLY(BUTYL CYANOACRYLATE); POLYMER; POLYSORBATE 80; POLYSORBATE 80 POLY(BUTYL CYANOACRYLATE); TACRINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SAFETY; MALE; NONHUMAN; RAT; SUSTAINED DRUG RELEASE;

EID: 73949146456     PISSN: 17528933     EISSN: 17528941     Source Type: Journal    
DOI: 10.1504/IJNBM.2009.027733     Document Type: Article

References (51)

1. Abdel Wahab, B.A., Petrov, V.E. and Alyautdin, R.N. (2005a) 'Brain targeting of nerve growth factor using poly(butylcyanoacrylate) nanoparticles', The Internet J. of Pharmacol., Vol.3, pp.723-731.
2. Abdel Wahab, B.A., Petrov, V.E., Trofimov, S.S., Voronina, T.T. and Alyautdin, R.N. (2005b) 'Transport of proserine through blood brain barrier using poly(butylcyanoacrylate) nanoparticles coated with polysorbate-80 in rats', J. Eur. College of Neuropsychopharmacol., Vol.15, pp.213-214.
3. Agnihotri, S.A., Mallikarjuna, N.N. and Aminabhavi, T.M. (2004) 'Recent advances on chitosanbased micro - and nanoparticles in drug delivery', J. Controlled Release, Vol.100, pp.5-28.
4. Allemann, E., Gravel, P., Leroux, J.C., Balant, L. and Gurny, R. (1997) 'Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement', J. Biomed. Mater. Res., Vol.37, pp.229-234.
5. Allemann, E., Gurny, R. and Deolker, E. (1993) 'Drug loaded nanoparticles: preparation methods and drug targeting issues', Eur. J. Pharm. Biopharm., Vol.39, pp.173-191.
6. Alyautdin, R., Gothier, D., Petrov, V., Kharkevich, D. and Kreuter, J. (1995) 'Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles', Eur. J. Pharm. Biopharm., Vol.41, pp.44-48.
7. Alyautdin, R.N., Petrov, V.E., Langer, K., Berthold, A., Kharkevich, D.A. and Kreuter, J. (1997) 'Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles', Pharm. Res., Vol.14, pp.325-328.
8. Alyautdin, R.N., Tezikov, E.B., Ramge, P., Kharkevich, D.A., Begley, D.J. and Kreuter, J. (1998) 'Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate study', J. Microencapsul., Vol.15, pp.67-74.
9. Banerjee, T., Mitra, S., Singh, A.K., Sharma, R.K. and Maitra, A. (2002) 'Preparation and biodistribution of ultrafine chitosan nanoparticles', Int. J. Pharm., Vol.243, pp.93-105.
10. Begley, D.J. (1996) 'The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system', J. Pharm. Pharmacol., Vol.48, pp.36-46.
11. Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J., Georgin, D., Fattal, E. Andreux, P. and Couvreu, P. (2001) 'Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery', Pharm. Research, Vol.18, pp.1157-1166. (Pubitemid 32900402)
12. Costa, P. and Lobo, J.M.S. (2001) 'Modelling and comparison of dissolution profiles', Eur. J. Pharm. Sci., Vol.13, pp.123-133.
13. Couvreur, P., Tulkens, P., Roland, M., Trouet, A. and Speiser, P. (1977) 'Nanocapsules: a new type of lysosomotropic carrier', FEBS Lett., Vol.84, pp.323-326.
14. Devineni, D., Klein-Szanto, A. and Gallo, J.M. (1995) 'Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors', J. Neurooncol., Vol.24, pp.143-152.
15. Fawaz, F., Guyot, M., Lagueny, A.M. and Devissaguet, J.Ph. (1997) 'Ciprofloxacin-loaded poly(isobutylcyanoacrylate) nanoparticles: preparation and characterization', Int. J. Pharm., Vol.154, pp.191-203.
16. Friese, A., Seiller, E., Quack, G., Lorenz, B. and Kreuter, J. (2000) 'Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system', Eur. J. Pharm. Biopharm., Vol.49, pp.103-109.
17. Gavini, E., Hegge, A.B., Rassu, G., Sanna, V., Testa, C., Pirisino, G., Karlsen, J. and Giunchedi, P. (2005) 'Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies', Int. J. Pharm., Vol.307, pp.9-15.
18. Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R.H. and Verbavatz, J.M. (1995) 'The controlled intravenous delivery of drugs using PEGcoated sterically stabilized nanospheres', Adv. Drug Deliv. Rev., Vol.16, pp.215-233.
19. Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E. and Harnisch, S. (2000) " Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption', Colloids Surfaces B: Biointerfaces, Vol. 18, pp.301-313.
20. Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D. and Speiser, P. (1983) 'Pharmacokinetics and distribution of a biodegradable drug-carrier', Int. J. Pharm., Vol.15, pp.335-345.
21. Gulyaev, A.E., Gelperina, S.E., Skidan, I.N., Antropov, A.S., Kivman, G. and Kreuter, J. (1999) 'Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles', Pharm. Res., Vol.16, pp.1564-1569.
22. Hallak, M. and Giacobini, E. (1989) 'Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain', Neuropharmacology, Vol.28, pp.199-206.
23. Hans, M.L. and Lowman, A.M. (2002) 'Biodegradable nanoparticles for drug delivery and targeting', Curr. Opin. Solid State Materi. Sci., Vol.6, pp.319-327.
24. Hejazi, R. and Amiji, M. (2004) 'Stomach-specific anti-H, pylori therapy part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils', Int. J. Pharm., Vol.272, pp.99-108.
25. Huwyler, J., Wu, D. and Pardridge, W.M. (1996) 'Brain delivery of small molecules using immunoliposomes', Proc. Natl. Acad. Sci., Vol.93, pp.14164-14169.
26. Jiang, Y., Zhang, Y. and Zhang, Z.R. (2003) 'Simultaneous determination of N-butyramide-tacrine and tacrine in mouse plasma and brain homogenate by high-performance liquid chromatography with a simple gradient solvent system', Journal of Chromatography B, Vol.791, pp.285-290.
27. Kreuter, J. (2001) 'Nanoparticulate systems for brain delivery of drugs', Adv. Drug Deliv. Rev., Vol.47, pp.65-81.
28. Kreuter, J. (2005) 'Application of nanoparticles for the delivery of drugs to the brain', International Congress Series, Vol.1277, pp.85-94.
29. Kreuter, J., Alyautdin, R.N., Kharkevich, D.A. and Ivanov, A.A. (1995) 'Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)', Brain Res., Vol.674, pp.171-174.
30. Kreuter, J., Petrov, V.E., Kharkevich, D.A. and Alyautdin, R.N. (1997) 'Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles', J. Control Release, Vol.49, pp.81-87.
31. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C. and Alyautdin, R. (2002) 'Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier', J. Drug Target, Vol.10, pp.317-325.
32. Kumar, V. and Becker, R.E. (1989) 'Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent for alzheimer's disease', Int. J. Cli. Pharmacol. Ther. Toxicol., Vol.27, pp.478-485.
33. Lobenberg, R., Araujo, L., Briesen, H., Rodgers, E. and Kreuter, J. (1998) 'Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats', J Control Release, Vol.50, pp.21-30. (Pubitemid 28044097)
34. Löbenberg, R., Araujo, L., von Brisen, H., Rodgers, E. and Kreuter, J. (1998) 'Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats', J. Control. Release, Vol.50, pp.21-30. (Pubitemid 28044097)
35. Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J. and Reszka, R. (2001) 'Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models', Pharm. Res., Vol.18, pp.1613-1619.
36. Marchal-Heussler, L., Maincent, P., Hoffman, M., Spittler, J. and Couvreur, P. (1990) 'Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticles preparations', Int. J. Pharm., Vol.58, pp.115-122.
37. Muller, R.H., Jacobs, C. and Kayser, O. (2001) 'Nanosuspensions as particulate drug formulations in therapy, rationale for development and what we can expect for the future', Adv. Drug Deliv. Rev., Vol.47, pp.3-19.
38. Peracchia, M.T., Fattal, E., Desmaele, D., Besnard, M., Noel, J.P. and Gomis, J.M. (1999) 'Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting', J. Control Release, Vol.60, pp.121-128. (Pubitemid 29255834)
39. Reddy, L.H. and Murthy, R.S.R. (2004) 'Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butylcyanoacrylate) nanoparticles synthesized by two different techniques', Biomed Papers, Vol.148, pp.161-166.
40. Sabolek, H.R., Bunce, J.G. and Chrobak, J.J. (2004) 'Intraseptal tacrine can enhance memory in cognitively impaired young rats', Neuroreport, Vol.5, pp.181-183.
41. Salmon, L., Montet, J.C., Oddoze, C., Montet, A.M., Portugal, H. and Michel, B.F. (2001) 'Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study', Therapie, Vol.56, pp.29-34.
42. Simeonova, M., Ivanova, T., Raikova, E., Georgieva, M. and Raikov, Z. (1988) 'Tissue distribution of polybutylcyanoacrylate nanoparticles carrying spin-labelled nitrosourea', Int. J. Pharm., Vol.43, pp.267-271.
43. Steiniger, S.C., Kreuter, J., Khalansky, A.S., Skidan, I.N., Bobruskin, A.I. and Smirnova, Z.S. (2004) 'Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles', Int. J. Cancer, Vol.109, pp.759-767.
44. Tamai, I. and Tsuji, A. (1996) 'Drug delivery through the blood brain barrier', Adv. Drug Del. Rev., Vol.19, pp.401-424.
45. Telting-Diaz, M. and Lunte, C.E. (1993) 'Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling', Pharm. Res., Vol.10, pp.44-48.
46. Tröster, S.D., Müller, U. and Kreuter, J. (1990) 'Modification of the body distribution of poly(methylmethacrylate) nanoparticles in rats by coating with surfactants', Int. J. Pharm., Vol.61, pp.85-100.
47. Van Dam, D., Hooge, R.D., Staufenbiel, M., Van Ginneken, C., Van Meir, F. and De Deyn, P.P. (2003) 'Age-dependent cognitive decline in the APP23 model precedes amyloid deposition', Eur. J. Neurosci., Vol.17, pp.388-396.
48. Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H. and Couvreur, P. (2003) 'Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications', Adv. Drug Deliv. Rev., Vol.55, pp.519-548.
49. Venable, N. and Kelly, P.H. (1990) 'Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice', Psychopharmacology (Berl), Vol.100, pp.215-221.
50. Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P. and Roland, M. (1990) 'Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles', Cancer Chemother. Pharmacol., Vol.26, pp.13-18.
51. Waser, P.G., Müller, U., Kreuter, J., Berger, S., Munz, K. and Kaiser, E. (1987) 'Localization of colloidal particles (liposomes, hexylcyanoacrylate nanoparticles and albumin nanoparticles) by histology and autoradiography in mice', Int. J. Pharm., Vol.39, pp.213-227.